Finally, targeted therapies for triple-negative breast cancer

Options

http://medicalxpress.com/news/2016-06-therapies-tr...

http://medicalxpress.com/news/2016-06-smart-tough-...


"At the American Society for Clinical Oncology (ASCO) Annual Meeting 2016, researchers present results of three clinical trials using new targeted therapies against triple negative breast cancer (TNBC). Each therapy uses a distinct strategy influenced by the immune system and all three have real potential to extend the lives of women whose cancers have progressed after previous treatments".

Comments

Categories